XGen Ventures

XGEN Venture operates as an Italian alternative investment fund manager, specializing in early-stage investments within the private research and development landscape of the life sciences sector. The firm identifies and supports novel solutions addressing high unmet medical needs, leveraging deep industry expertise to guide portfolio companies from discovery through development. Their approach focuses on nurturing the next generation of life science ventures.

The firm was established in 2021 by the former Genextra team, bringing together over 15 years of collective experience in the intricate processes of startup creation, scientific discovery, and product development. This foundational insight, born from extensive operational involvement in the life sciences, positioned the team to identify and back promising early-stage companies. Daniele Scarinci, a key figure from the Genextra team, serves on the board, with Paolo Fundarò as Chief Executive Officer.

XGEN Venture primarily serves early-stage private research and development companies in life sciences seeking capital and strategic guidance. The firm's overarching vision is to build groundbreaking life science entities, fostering innovation that translates into impactful solutions for critical health challenges. They aim to be a pivotal partner in realizing transformative advancements in medicine.